Canadian cannabis producer MedReleaf Corp. has introduced a product identification number for 57 of its medical marijuana products in an effort to facilitate coverage in employer-sponsored benefits plans.
Product identification numbers are similar to traditional drug identification numbers, according to a press release. They’re designed to make it easier for employers and other private payers to classify and incorporate pharmaceutical and health-care products into benefits plans.
Read: Medical marijuana patients may use less than prescribers dole out
“Medical cannabis is being covered by an ever-increasing number of employers across Canada through health spending accounts and extended health benefits plans, but without an identification number for each product, it can be difficult to incorporate and track the use of our products within core health benefits programs,” said Robert Gora, senior director of physician outreach at the organization.
“Introducing PINs will help willing insurers and employers to list MedReleaf’s cannabis medicines on their formularies, improving access and cannabis drug coverage for patients across Canada.”
Read: Medical marijuana cases highlight need for precise wording in benefits plans